Resultados da pesquisa - (( j l comps con neto ) OR ((( a daily completed phase non ) OR ( 3 nail comor dan non ))))

Pesquisas alternativas:
comps » comes (Expandir a Pesquisa), camps (Expandir a Pesquisa), combs (Expandir a Pesquisa)
neto » net (Expandir a Pesquisa)
completed » complete (Expandir a Pesquisa)
nail » natl (Expandir a Pesquisa), neil (Expandir a Pesquisa), nair (Expandir a Pesquisa)
comor » comorb (Expandir a Pesquisa), comer (Expandir a Pesquisa), compr (Expandir a Pesquisa)

41

LONG-TERMS RESULTS OF A TRIAL OF CONCURRENT CHEMOTHERAPY AND ESCALATING DOSES OF RADIATION FOR UNRESECTABLE NON–SMALL CELL LUNG CANCER: NCCTG N0028 (ALLIANCE)

LONG-TERMS RESULTS OF A TRIAL OF CONCURRENT CHEMOTHERAPY AND ESCALATING DOSES OF RADIATION...

Por Schild, Steven E., Hillman, Shauna L., Tan, Angelina D., Ross, Helen J., McGinnis, William L., Garces, Yolanda A., Graham, David L., Adjei, Alex A., Jett, James R.
Publicado no J Thorac Oncol (2017)

“... daily fractions and concurrent weekly carboplatin and paclitaxel. Of these, twenty had stage III disease...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

42

Induction therapy for Locally Advanced, Resectable Esophagogastric Cancer: A Phase I Trial of Vandetanib (ZD6474), Paclitaxel, Carboplatin, 5-Fluorouracil and Radiotherapy Followed by Resection

Induction therapy for Locally Advanced, Resectable Esophagogastric Cancer: A Phase I Trial...

Por Boland, Patrick M, Meyer, Joshua E, Berger, Adam C, Cohen, Steven J, Neuman, Tzahi, Cooper, Harry S, Olszanski, Anthony J, Davey, Monica, Cheng, Jonathan D, Lebenthal, Abraham, Burtness, Barbara A, Scott, Walter J, Astsaturov, Igor A
Publicado no Am J Clin Oncol (2017)

“... without prior therapy were enrolled in a 3+3 phase 1 design. Patients received once daily vandetanib...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

43

Phase II study of docetaxel, cisplatin and capecitabine as preoperative chemotherapy in resectable gastric cancer

Phase II study of docetaxel, cisplatin and capecitabine as preoperative chemotherapy in resectable gastric cancer

Por Dassen, Anneriet E, Bernards, Nienke, Lemmens, Valery E P P, van de Wouw, Yes A J, Bosscha, Koop, Creemers, Geert-Jan, Pruijt, Hans J F M
Publicado no World J Gastrointest Surg (2016)

“...)) and capecitabine (1.875 mg/m(2) orally on day 1-14, two daily doses) repeated every three weeks, followed...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

44

Acceptability and potential effectiveness of a foot drop stimulator in children and adolescents with cerebral palsy

Acceptability and potential effectiveness of a foot drop stimulator in children and adolescents with cerebral palsy

Por PROSSER, LAURA A, CURATALO, LINDSEY A, ALTER, KATHARINE E, DAMIANO, DIANE L
Publicado em 2012

“... to continue using FES beyond that phase. Average daily use was 5.6 hours (SD 2.3). Improved dorsiflexion...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

45

Combination of the histone deacetylase inhibitor vorinostat with bevacizumab in patients with clear-cell renal cell carcinoma: a multicentre, single-arm phase I/II clinical trial

Combination of the histone deacetylase inhibitor vorinostat with bevacizumab in patients with clear-cell renal cell carcinoma: a multicentre, single-arm phase I/II clinical trial

Por Pili, Roberto, Liu, Glenn, Chintala, Sreenivasulu, Verheul, Hendrick, Rehman, Shabnam, Attwood, Kristopher, Lodge, Martin A, Wahl, Richard, Martin, James I, Miles, Kiersten Marie, Paesante, Silvia, Adelaiye, Remi, Godoy, Alejandro, King, Serina, Zwiebel, James, Carducci, Michael A
Publicado no Br J Cancer (2017)

“... of vorinostat 200 mg orally two times daily × 2 weeks, and bevacizumab 15 mg kg(−1) intravenously every 3 weeks...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

46

Phase I clinical and pharmacokinetic study of sorafenib in combination with carboplatin and paclitaxel in patients with advanced non–small cell lung cancer

Phase I clinical and pharmacokinetic study of sorafenib in combination with carboplatin and paclitaxel in patients with advanced non–small cell lung cancer

Por Okamoto, Isamu, Miyazaki, Masaki, Morinaga, Ryotaro, Kaneda, Hiroyasu, Ueda, Shinya, Hasegawa, Yoshikazu, Satoh, Taroh, Kawada, Akira, Fukuoka, Masahiro, Fukino, Koichi, Tanigawa, Takahiko, Nakagawa, Kazuhiko
Publicado em 2009

Assuntos: “...Phase I Studies...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

47

$Efficacy and Safety of Gemcitabine (G), Carboplatin (C), Dexamethasone (D), and Rituximab (R) in Patients with Relapsed/Refractory Lymphoma: A Prospective Multi-center Phase II Study of by the Puget Sound Oncology Consortium (PSOC)$

Efficacy and Safety of Gemcitabine (G), Carboplatin (C), Dexamethasone (D), and Rituximab (R) in Patients with Relapsed/Refractory Lymphoma: A Prospective Multi-center Phase II Study of by the Puget Sound...

Por Gopal, Ajay K., Press, Oliver W., Shustov, Andrei R., Petersdorf, Stephen H., Gooley, Ted A., Daniels, Jasmine T., Garrison, Mitchell A., Gjerset, George F., Lonergan, Matthew, Murphy, Anne E., Smith, Julie C., Pagel, John M.
Publicado em 2010

“...We conducted a multi-center phase II trial of gemcitabine (G), carboplatin (C), dexamethasone (D...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

48

Everolimus in combination with rituximab induces complete responses in heavily pretreated diffuse large B-cell lymphoma

Everolimus in combination with rituximab induces complete responses in heavily pretreated diffuse large B-cell lymphoma

Por Barnes, Jeffrey A., Jacobsen, Eric, Feng, Yang, Freedman, Arnold, Hochberg, Ephraim P., LaCasce, Ann S., Armand, Philippe, Joyce, Robin, Sohani, Aliyah R., Rodig, Scott J., Neuberg, Donna, Fisher, David C., Abramson, Jeremy S.
Publicado em 2013

“...Diffuse large B-cell lymphoma is an aggressive non-Hodgkin's lymphoma without a standard therapy...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

49

EFFECT OF MORNING AND EVENING RAMIPRIL TAKING ON AMBULATORY BLOOD PRESSURE PROFILE IN PATIENTS WITH ARTERIAL HYPERTENSION

Por V. M. Gorbunov, E. J. Fedorova, A. D. Deev, E. V. Platonova, O. J. Isaikina
Publicado em 2016-01-01

Assuntos: “...non-dippers...”
Obter o texto integral

Artigo

50

Quality-of-life findings from a randomised phase-III study of XELOX vs FOLFOX-6 in metastatic colorectal cancer

Quality-of-life findings from a randomised phase-III study of XELOX vs FOLFOX-6 in metastatic colorectal cancer

Por Conroy, T, Hebbar, M, Bennouna, J, Ducreux, M, Ychou, M, Llédo, G, Adenis, A, Faroux, R, Rebischung, C, Kockler, L, Douillard, J Y
Publicado em 2010

“...BACKGROUND: A phase-III trial showed the non-inferiority of oral capecitabine plus oxaliplatin...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

51

A Phase II study of Capecitabine, Oxaliplatin, Bevacizumab and Cetuximab in the Treatment of Metastatic Colorectal Cancer

A Phase II study of Capecitabine, Oxaliplatin, Bevacizumab and Cetuximab in the Treatment of Metastatic Colorectal Cancer

Por WONG, NAN SOON, FERNANDO, NISHAN H., NIXON, ANDREW B., CUSHMAN, STEPHANIE, AKLILU, MEBEA, BENDELL, JOHANNA C., MORSE, MICHAEL A., BLOBE, GERARD C., ASHTON, JILL, PANG, HERBERT, HURWITZ, HERBERT I.
Publicado em 2011

“... 130 mg/m(2) and bevacizumab 7.5 mg/kg every three weeks, capecitabine 850 mg/m(2) twice daily on days...”
Obter o texto integral
Obter o texto integral

Artigo

52

A phase I trial of concurrent chemoradiotherapy with non-split administration of docetaxel and cisplatin for dry stage III non-small-cell lung cancer (JCOG9901DI)

A phase I trial of concurrent chemoradiotherapy with non-split administration of docetaxel...

Por Hida, Naoya, Okamoto, Hiroaki, Misumi, Yuuki, Sato, Akira, Ishii, Mari, Kashizaki, Fumihiro, Shimokawa, Tsuneo, Shimizu, Teppei, Watanabe, Koshiro
Publicado em 2012

“.... METHODS: Patients (aged ≤70 years) with unresectable dry stage III non-small-cell lung cancer (NSCLC...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

53

Polyphenon E, Non-futile at Neuroprotection in Multiple Sclerosis but Unpredictably Hepatotoxic: Phase I Single Group and Phase II Randomized Placebo-Controlled Studies

Polyphenon E, Non-futile at Neuroprotection in Multiple Sclerosis but Unpredictably Hepatotoxic...

Por Lovera, Jesus, Ramos, Alexander, Devier, Deidre, Garrison, Virginia, Kovner, Blake, Reza, Tara, Koop, Dennis, Rooney, William, Foundas, Anne, Bourdette, Dennis
Publicado no J Neurol Sci (2015)

“... capsules from a new lot (L0206306). Both lots had similar levels of EGCG but differed in the levels...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

54

Efficacy of anakinra in active ankylosing spondylitis: a clinical and magnetic resonance imaging study

Efficacy of anakinra in active ankylosing spondylitis: a clinical and magnetic resonance imaging study

Por Tan, A, Marzo-Ortega, H, O'Connor, P, Fraser, A, Emery, P, McGonagle, D
Publicado em 2004

“.../osteitis using magnetic resonance imaging (MRI). Methods: A 3 month open label study of anakinra (100 mg...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

55

Are the effects of a non-drug multimodal activation therapy of dementia sustainable? Follow-up study 10 months after completion of a randomised controlled trial

Are the effects of a non-drug multimodal activation therapy of dementia sustainable? Follow-up...

Por Luttenberger, Katharina, Hofner, Benjamin, Graessel, Elmar
Publicado em 2012

“... and 0.22, respectively. CONCLUSIONS: A multimodal non-drug therapy of dementia resulted in stabilisation...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

56

$A Phase 2 Study of Belinostat (PXD101) in Patients with Relapsed or Refractory Acute Myloid Leukemia or Patients Over 60 with Newly-Diagnosed Acute Myloid Leukemia: A California Cancer Consortium Study$

A Phase 2 Study of Belinostat (PXD101) in Patients with Relapsed or Refractory Acute Myloid...

Por Kirschbaum, Mark H., Foon, Kenneth A., Frankel, Paul, Ruel, Christopher, Pulone, Bernadette, Tuscano, Joseph M., Newman, Edward M.
Publicado em 2014

“...We performed a phase II study of belinostat in patients with acute myloid leukemia (AML...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

57

Erlotinib, cabozantinib, or erlotinib plus cabozantinib as second- or third-line treatment of patients with EGFR wild-type advanced non-small cell lung cancer (ECOG-ACRIN 1512): a phase 2 randomised controlled trial

Erlotinib, cabozantinib, or erlotinib plus cabozantinib as second- or third-line treatment of patients with EGFR wild-type advanced non-small cell lung cancer (ECOG-ACRIN 1512): a phase 2 randomised...

Por Neal, Joel W., Dahlberg, Suzanne E., Wakelee, Heather A., Aisner, Seena C., Bowden, Michaela, Huang, Ying, Carbone, David P., Gerstner, Gregory J., Lerner, Rachel E., Rubin, Jerome L., Owonikoko, Taofeek K., Stella, Philip J., Steen, Preston D., Khalid, Ahmed Ali, Ramalingam, Suresh S.
Publicado no Lancet Oncol (2016)

“...BACKGROUND: Erlotinib is approved for the treatment of all patients with advanced non-small cell...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

58

A Phase 1/2 Trial of HQK-1001, an Oral Fetal Globin Inducer, in Sickle Cell Disease

A Phase 1/2 Trial of HQK-1001, an Oral Fetal Globin Inducer, in Sickle Cell Disease

Por Kutlar, Abdullah, Ataga, Kenneth, Reid, Marvin, Vichinsky, Elliott P., Neumayr, Lynne, Blair-Britt, Loray, Labotka, Richard, Glass, Jonathan, Keefer, Jeffrey R., Wargin, William A., Berenson, Ronald, Perrine, Susan P.
Publicado em 2012

“... agent, was evaluated in a randomized, blinded, dose-ranging Phase I/II trial in 24 adult patients...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

59

Multicenter Phase IB Trial of Carboxyamidotriazole Orotate and Temozolomide for Recurrent and Newly Diagnosed Glioblastoma and Other Anaplastic Gliomas

Multicenter Phase IB Trial of Carboxyamidotriazole Orotate and Temozolomide for Recurrent and Newly Diagnosed Glioblastoma and Other Anaplastic Gliomas

Por Omuro, Antonio, Beal, Kathryn, McNeill, Katharine, Young, Robert J., Thomas, Alissa, Lin, Xuling, Terziev, Robert, Kaley, Thomas J., DeAngelis, Lisa M., Daras, Mariza, Gavrilovic, Igor T., Mellinghoff, Ingo, Diamond, Eli L., McKeown, Andrew, Manne, Malbora, Caterfino, Andrew, Patel, Krishna, Bavisotto, Linda, Gorman, Greg, Lamson, Michael, Gutin, Philip, Tabar, Viviane, Chakravarty, Debyani, Chan, Timothy A., Brennan, Cameron W., Garrett-Mayer, Elizabeth, Karmali, Rashida A., Pentsova, Elena
Publicado no J Clin Oncol (2018)

“...PURPOSE: Carboxyamidotriazole orotate (CTO) is a novel oral inhibitor of non–voltage-dependent...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

60

Phase I study of the aurora A kinase inhibitor alisertib with induction chemotherapy in patients with acute myeloid leukemia

Phase I study of the aurora A kinase inhibitor alisertib with induction chemotherapy in patients with acute myeloid leukemia

Por Fathi, Amir T., Wander, Seth A., Blonquist, Traci M., Brunner, Andrew M., Amrein, Philip C., Supko, Jeffrey, Hermance, Nicole M., Manning, Amity L., Sadrzadeh, Hossein, Ballen, Karen K., Attar, Eyal C., Graubert, Timothy A., Hobbs, Gabriela, Joseph, Christelle, Perry, Ashley M., Burke, Meghan, Silver, Regina, Foster, Julia, Bergeron, Meghan, Ramos, Aura Y., Som, Tina T., Fishman, Kaitlyn M., McGregor, Kristin L., Connolly, Christine, Neuberg, Donna S., Chen, Yi-Bin
Publicado no Haematologica (2017)

“...), and the recommended phase 2 dose was established at 30mg twice daily. Common therapy-related toxicities included...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

[1]
Anterior
1
2
3
4
5
6
7
8
9
10
11
Seguinte
[23]